The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
MEK inhibitor combined with RTK inhibitor (trametinib plus anlotinib) in non-G12C KRAS-mutant non-small cell lung cancer: A new strategy.
 
Baohui Han
No Relationships to Disclose
 
Jun Lu
No Relationships to Disclose
 
Hua Zhong
No Relationships to Disclose
 
Tianqing Chu
No Relationships to Disclose
 
Wei Zhang
No Relationships to Disclose
 
Minjuan Hu
No Relationships to Disclose
 
Chunlei Shi
No Relationships to Disclose
 
Liwen Xiong
No Relationships to Disclose
 
Aiqin Gu
No Relationships to Disclose
 
Huimin Wang
No Relationships to Disclose
 
Yuqing Lou
No Relationships to Disclose
 
Yanwei Zhang
No Relationships to Disclose
 
Runbo Zhong
No Relationships to Disclose
 
Zhiqiang Gao
No Relationships to Disclose